• Hangzhou Karssen Chemical Co.Ltd.
    is a chemical supplier and dedicated to international trade business of chemicals.
  • Pay attention to R&D
    intermediate;fine chemical;biocide; surfactant;cosmetic;food additive;agrochemical;animal health ;dietary supplement
  • Service, Brand, and Quality
    Glutaric dialdehyde;Vinyl ether;Intermediates;Aliphatic epoxy resin; Polymer;Customised chemicals
 Name: Doxycycline hydrochloride

Chemical name: Doxycycline hydrochloride

Cas number: 10592-13-9

Molecular formula: C22H25ClN2O8

Product specification/standard: CVP, EP


Packing style and Storage:
25kg/drum or as per customer request,
class  , PG  , UN-non-dangerous cargo
store under dried and mild temperature condition;

Product application:
As a broad-spectrum antibiotic, Doxycycline Hydrochloride has many advantages such as broad-spectrum, high efficiency and long-lasting effect, which can inhibit or kill many bacteria. In the category, it is categorized as a rapid bacteriostatic agent due to its rapid bacterial inhibition, and exhibits bactericidal effects at high concentrations. As a semi-synthetic class of second-generation tetracyclines, its antimicrobial spectrum is similar to that of the first-generation tetracyclines, but the antimicrobial activity is four times higher than that of the first-generation of gentamycin, tetracycline, and hygromycin, etc. and it is the strongest tetracycline antimicrobial with the strongest antimicrobial activity that is commonly used in the clinic at the present time.


Respected customers:
Thank you for browsing our website, please fill in following information, (* is required), and it will be sent via E-mail, we will contact you, thank you!

Your name: *
Subject *
Your e-mail *
Your message *
verification code:
   

Back

  • ADD: RM926, BUILDING 2, LONGFOR MANSION, PENGBU, SHANGCHENG, HANGZHOU, ZHEJIANG, CHINA

  • Tel: +86-571-87234511 87234512

    Fax: +86-571-87234510

Copyright(C)2024,Hangzhou Karssen Chemical Co.Ltd(HKC) All Rights Reserved. Supported by ChemNet Copyright Notice